Form 4 for MIRM Mirum Pharmaceuticals, Inc.
Accepted 2024-01-09 00:00:00 ET · period of report 2024-01-08 · accession 0001415889-24-000884 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-01-09 | 2024-01-08 | MIRM | Radovich Peter | COO | S - Sale | $28.03 | -1,408 | 36.5K | -4% | -$39.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-01-08 | S | D | 1,408 | $28.03 | 36,485 | D | — | — |